08:00 , Dec 17, 2001 |  BioCentury  |  Finance

Ebb & Flow

As the rumor mill churned with news of Amgen taking out Immunex , the size of the combined mega-biotech continued to shrink as AMGN's shares tumbled amid uncertainty over the presumed deal terms. In fact,...
08:00 , Dec 17, 2001 |  BioCentury  |  Finance

Ebb & Flow

As the rumor mill churned with news of Amgen taking out Immunex , the size of the combined mega-biotech continued to shrink as AMGN's shares tumbled amid uncertainty over the presumed deal terms. In fact,...
08:00 , Dec 12, 2001 |  BC Extra  |  Financial News

Aradigm raises $48.4 million

Drug delivery company ARDM raised $48.4 million through the sale of 2 million shares of convertible preferred stock at $24.20. Investors included New Enterprise Associates; Camden Partners; Castle Creek Partners; and Domain Public Equity Partners....